|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1997-5-20
|
|
pubmed:abstractText |
Tissue factor pathway inhibitor (TFPI), an endogenous protease, is a potent inhibitor of the extrinsic pathway of coagulation. To determine whether TFPI could be used as an alternative to systemic heparin and dextran in vein bypass grafting procedures, we compared the efficacy of these agents in a blinded trial using a pig model of lower extremity vein bypass grafting.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0741-5214
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
726-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9129630-Animals,
pubmed-meshheading:9129630-Anticoagulants,
pubmed-meshheading:9129630-Blood Coagulation,
pubmed-meshheading:9129630-Cardiopulmonary Bypass,
pubmed-meshheading:9129630-Dextrans,
pubmed-meshheading:9129630-Disease Models, Animal,
pubmed-meshheading:9129630-Factor Xa,
pubmed-meshheading:9129630-Female,
pubmed-meshheading:9129630-Femoral Artery,
pubmed-meshheading:9129630-Fibrinolytic Agents,
pubmed-meshheading:9129630-Follow-Up Studies,
pubmed-meshheading:9129630-Heparin,
pubmed-meshheading:9129630-Hindlimb,
pubmed-meshheading:9129630-Infusions, Intravenous,
pubmed-meshheading:9129630-Injections, Intravenous,
pubmed-meshheading:9129630-Lipoproteins,
pubmed-meshheading:9129630-Partial Thromboplastin Time,
pubmed-meshheading:9129630-Phosphates,
pubmed-meshheading:9129630-Random Allocation,
pubmed-meshheading:9129630-Saphenous Vein,
pubmed-meshheading:9129630-Serine Proteinase Inhibitors,
pubmed-meshheading:9129630-Single-Blind Method,
pubmed-meshheading:9129630-Sodium Chloride,
pubmed-meshheading:9129630-Swine,
pubmed-meshheading:9129630-Thrombosis,
pubmed-meshheading:9129630-Time Factors,
pubmed-meshheading:9129630-Vascular Patency
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
A blinded trial of local recombinant tissue factor pathway inhibitor versus either local or systemic heparin in a vein bypass model.
|
|
pubmed:affiliation |
Surgical Service at the San Francisco Department of Veterans Affairs Medical Center, CA 94117, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
